The effect of several chelating agents (diethyldithiocarbamic acid, DDC; nitrilotriacetic acid, NTA; 2,3-dimercaptopropanol, BAL; d,-penicillamine, PEN; 2,3-dimercaptosuccinic acid, DMSA; ethylenediaminetetraacetic acid, EDTA; and diethylenetriaminepentaacetic acid, DTPA) on the toxicity, distribution and excretion of cadmium (Cd) was determined in mice. When chelators were administered immediately after Cd, significant increases in survival were noted after treatment with DMSA, EDTA, and DTPA. DTPA, followed by EDTA and then DMSA, were consistently the most effective in decreasing the tissue concentrations of Cd and increasing the excretion of Cd. NTA, BAL, DDC and PEN had no beneficial effects.
The effect of several chelating agents (diethyldithiocarbamic acid, DDC; nitrilotriacetic acid, NTA; 2,3-dimercaptopropanol, BAL; d,-penicillamine, PEN; 2,3-dimercaptosuccinic acid, DMSA; ethylenediaminetetraacetic acid, EDTA; and diethylenetriaminepentaacetic acid, DTPA) on the toxicity, distribution and excretion of cadmium (Cd) was determined in mice. When chelators were administered immediately after Cd, significant increases in survival were noted after treatment with DMSA, EDTA, and DTPA. DTPA, followed by EDTA and then DMSA, were consistently the most effective in decreasing the tissue concentrations of Cd and increasing the excretion of Cd. NTA, BAL, DDC and PEN had no beneficial effects.
The effects of increasing the time interval between Cd administration and initiation of chelation therapy was determined by using a single administration of DTPA, EDTA, and DMSA. Mice treated immediately after Cd administration excreted approximately 50% of the administered dose of Cd compared to 0.2% in controls. Ireatment with chelator at later times significantly increased Cd excretion but the magnitude of the effect was much less than that seen in mice treated immediately after Cd.
To determine the role of MT in the acute decrease in chelator efficacy following Cd poisoning, rats were injected IV with Cd followed by DTPA at various times after Cd. Although DTPA reduced Cd content in the various organs when given immediately after Cd, the chelator was ineffective at all later times. Increases in hepatic and renal metallothionein (MT) did not occur until 2 hr after Cd, and did not coincide with the earlier drop in chelator efficacy. Blockade of MT synthesis by actinomycin D failed to eliminate this decreased DTPA effectiveness. Therefore, it appears that MT does not play an important role in the acute decrease in efficacy of chelation therapy for Cd poisoning. The effect of repeated daily administration of chelators on the distribution and excretion of Cd was studied by administering chelators daily for 5 days starting 48 hr after Cd. DTPA, EDTA, DMSA and BAL significantly increased the urinary elimination of Cd. Thus, mobilization of Cd into urine occurs with repeated chelation therapy, which may decrease tissue concentrations of Cd and reduce the toxicity of the metal.
The LD50 values for the various chelators studied are shown in Table 1 . Marked differences in the toxicity of the chelators was observed: NTA, BAL and PEN were very toxic, while DDC, DMSA and DTPA were moderately toxic, and EDTA was only slightly toxic. The dose of chelator chosen for the subsequent studies was approximately one-fourth of the respective LD.% value.
The effect ofthe various chelating agents on the lethality of Cd is shown in Figure 1 . Mice which received saline after Cd are shown as control. The effect of the chelators on tissue distribution of Cd is shown in Figure 3 . Note that the scale of the ordinate changes in the bottom two panels of the figure. The concentration of Cd (rig Cd/g tissue) is shown for each treatment group. The upper left quadrant shows the concentration of Cd found in liver, the main storage site of administered Cd in the body. Treatment with PEN, DMSA, EDTA and DTPA significantly reduced the amount of Cd found in liver with DTPA being the most effective.
The upper right quadrant of Figure 3 shows the results from kidney, the main target organ of chronic Cd exposure. The agents which decreased tissue Cd levels in kidney were EDTA and DTPA. which had not yet received chelator treatment are omitted for clarity.
During the first 24 hr after Cd administration (day 1, Fig. 4 ), the first three groups (0, 2, and 12 hr) received chelation treatment. Saline-treated controls in these three groups excreted approximately 1 jg Cd/kg during this period. Treatment with DTPA significantly increased urinary excretion of Cd in all three groups during day 1. The DTPA-treated mice excreted 500, 50 and 2.5 jg Cd/kg when treated at 0, 2 and 12 hr, respectively. Treatment with either EDTA or DMSA at 0 or 2 hr after Cd also markedly increased urinary elimination of Cd.
Excretion of Cd into urine during day 2 is shown in the second panel from the top of Figure  4 .
The third panel from the top of Figure 4 shows the urinary elimination of Cd during the third day after Cd administration. The bottom panel of Figure 4 shows the urinary elimination of Cd during day 5. After 5 days, mice which received DTPA or DMSA immediately after Cd (0 hr) continued to excrete more Cd than controls. Similarly, mice which received DTPA 72 hr after Cd excreted more Cd than controls.
The effect of administration of DTPA, EDTA, or DMSA immediately after Cd on its elimination into feces is shown in Figure 5 . Treatment Cd concentrations were only noted in mice that received chelation therapy immediately after Cd. Tb determine the time of onset for decreased effectiveness of chelators after Cd exposure, rats were injected with DTPA (90 mg/kg, IP) at various times (0, 15, 30, 60 and 120 min) after Cd exposure (1 mg/kg, IV; time 0), and 24 hr later the amount of Cd in various tissues was quantified (Fig. 10) . DTPA markedly lowered the amount of Cd remaining in liver, kidney, lung, stomach, heart, and brain at 24 hr when given immediately after Cd. However, if DTPA was delayed as little as 15 min, the chelator was ineffective. The amount of Cd in the various tissues of rats receiving DTPA at 15, 30, 60 or 120 min following Cd was not different from control (no chelator). The retention of Cd in the spleen (data not shown) was not affected by DTPA therapy.
The concentration of MT in liver and kidney at various times following Cd (1 mg Cd/kg, IV) treatment is shown in Figure 11 . There was no significant increase in MT concentration in either organ until 2 hr after Cd injection. Between 2 and 24 hr there was a significant increase in MT in both liver and kidney. MT levels reached a plateau in both organs between 4 and 12 hr after Cd injection which was 6.4 and 2.5 times higher than basal levels for liver and kidney, respectively. The effect of actinomycin D pretreatment (1.25 mg/kg, IP) on the induction of hepatic and renal MT 4 hr following Cd (when MT levels are approximately maximal) is shown in Figure 12 . In animals pretreated with vehicle 1 hr prior to Cd, there was a marked increase in both hepatic and renal MT concentrations. However, rats receiving actinomycin D had no significant increase in MT over controls in either organ.
Despite the block of MT synthesis with actinomycin D, the pronounced decrease in DTPA efficacy was still evident at 15 min (Fig. 13) was not significantly different from that in rats that did not receive the chelator. The efficacy of DTPA was also determined in newborn rats (5-day-old) following Cd injection (1 mg Cd/kg, IV). Hepatic MT concentration in 5-day-old rats without any pretreatment was 1260 + 45 jig MT/g wet weight (x + SE), which is approximately 36 times the basal levels in young adult rat liver (35.4 + 7.5). Despite these high levels of hepatic MT in newborn rats, DTPA was still effective if given immediately following Cd (Fig. 14) . However, when DTPA administration was delayed to 2 hr after Cd injection, it became ineffective in both the newborn and adult rats.
The effect of repeated daily administration of chelators on the distribution and excretion of Cd was studied by administering chelators daily for 5 days starting 48 hr after Cd. Daily Cd excretion (jig/kg body weight) by mice that received one of the various chelators or saline from day 3 to day 7 (post-Cd administration) is shown in Figure 15 . During the first day of treatment (day 3) significant increases in urinary elimination of Cd were found in mice treated with DTPA, EDTA, DMSA, and BAL. DTPA produced the greatest increase in urinary elimination (approximately 100-fold). Al The effect of repeated daily administration of chelators on the fecal elimination of Cd was also determined. Fecal excretion, the major route of elimination of Cd, decreased with time after administration of Cd in control animals. The excretion of Cd into feces of control mice during the first and second days was 96.4 + 11.7 and 40.5 ± 3.6 jg Cd/kg, respectively. Only DDC significantly increased the fecal elimination of Cd (Table 2), ranging from a 2-fold (day 3) to a 10-fold increase (day 7). All other chelators had no effect on fecal Cd elimination (data not shown).
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